Warren Wen

Summary

Affiliation: Purdue Pharma
Country: USA

Publications

  1. doi request reprint Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis
    Warren Wen
    Purdue Pharma LP, One Stamford Forum, 7th Floor, Stamford, CT 06901, USA
    Expert Opin Drug Saf 12:309-19. 2013
  2. doi request reprint A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain
    Steven R Ripa
    Purdue Pharma LP, One Stamford Forum, Stamford, CT 06901 3431, USA
    Expert Opin Pharmacother 13:1229-41. 2012
  3. doi request reprint Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study
    Deborah J Steiner
    Purdue Pharma L P, Stamford, Connecticut 06901 3431, USA
    J Pain Symptom Manage 42:903-17. 2011

Collaborators

  • Steven R Ripa
  • Catherine Munera
  • Deborah J Steiner
  • Bill H McCarberg
  • Craig J Landau
  • Steve Sitar
  • Gosford Sawyerr
  • Craig Landau

Detail Information

Publications3

  1. doi request reprint Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis
    Warren Wen
    Purdue Pharma LP, One Stamford Forum, 7th Floor, Stamford, CT 06901, USA
    Expert Opin Drug Saf 12:309-19. 2013
    ..To characterize the profile of application site reactions (ASRs) for patients treated with the buprenorphine transdermal system (BTDS) in chronic pain studies...
  2. doi request reprint A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain
    Steven R Ripa
    Purdue Pharma LP, One Stamford Forum, Stamford, CT 06901 3431, USA
    Expert Opin Pharmacother 13:1229-41. 2012
    ..The objective of this study was to evaluate continued pain control and tolerability of converting patients from Vicodin (hydrocodone/acetaminophen; HCD/APAP) to the buprenorphine transdermal system (BTDS)...
  3. doi request reprint Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study
    Deborah J Steiner
    Purdue Pharma L P, Stamford, Connecticut 06901 3431, USA
    J Pain Symptom Manage 42:903-17. 2011
    ..In this randomized, placebo-controlled study with an enriched enrollment design, the buprenorphine transdermal system (BTDS) was found to be efficacious and generally well tolerated...